口腔鳞状细胞癌现状

Abstract

CLC Number:

R739.85

chen xin. Current situation of oral squamous cell carcinoma[J]. , 2017, 37(5): 462-465.

[1].Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: Globocan 2008.[J]. Int J Cancer, 2010, 127(12): 2893-917.
[2].Ferlay J, Bray F, Pisani P, et al. Globocan 2002.Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. Updated 2004. http://www-dep.iarc.fr/ Accessed March 31, 2009.
[3].Mayne ST, Morse DE, Winn DM. Cancers of the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF, editors. Cancer epidemiology and prevention, 3rd ed. New York: Oxford University Press; 2006. pp 674-696.
[4]. Johnson N, Franceschi S, Ferlay J, et al. Tumours of the oral cavity and oropharynx-squamous cell carcinoma.In: Barnes L, Eveson JW, Reichart P, Sidransky D,editors. Pathology and genetics of head and neck tumours. Lyon, France: World Health Organization/IARC Press; 2005. pp 168-175.
[5].Ferlay, J., I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser, and others. 2013. GLOBOCAN 2012 V1.0, Cancer Incidence and Mortality Worldwide: IARC Cancerbase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer.http://globocan.iarc.fr.
[6].de Camargo Cancela M, Voti L, Guerra-Yi M, et al. Oral cavity cancer in developed and in developing　countries: population-based incidence.[J].Head Neck, 2010, 32: 357-67.
[7].National Bureau of Statistics of China.China Statistical Yearbook, 2010. Beijing, China: China Statistics Press; 2010.
[8].Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer.[J].Oral Oncol, 2009, 45: 309-16.
[9].Parkin DM, Bray F, Ferlay J, et al.Global cancer statistics, 2002.[J].CA Cancer J Clin, 2005, 55(2):74-108.
[10].Torre LA, Bray F, Siegel RL,et al.Global cancer statistics, 2012.[J].CA Cancer J Clin, 2015, 65(2):87-108
[11].Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014, 64(1): 9-29.
[12].Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2):115-32.
[13].Sankaranarayanan R, Ramadas K, Amarasinghe H, et al.Oral Cancer: Prevention, Early Detection, and Treatment. Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: Disease Control Priorities, Third Edition (Volume 3). Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2015 Nov. Chapter 5:192-195
[14].Tsantoulis PK, Kastrinakis NG, Tourvas AD, et al. Advances in the biology of oral cancer.[J]. Oral Oncol, 2007, 43: 523-534.
[15].Jemal A, SiegelR, XuJ, et al. Cancer statistics,2010.[J]. CA Cancer J Clin, 2010, 60(5):277-300.
[16].Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009.[J]. CA Cancer J Clin, 2009 ,59(4):225-49.
[17].Siegel R, Naishadham D, Jemal A.Cancer statistics.[J]. CA　Cancer J Clin,2012,62(1):10-29
[18].Tanaka S, Sobue T.Comparison of oral and pharyngeal　cancer mortality in five countries: France, Italy, Japan, UK and　USA from the WHO Mortality Database (1960-2000) .[J]. Jpn J Clin　Oncol,2005,35(8):488-491
[19].NohataN, HanazawaT, KikkawaN, et al. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).[J]. Hum Genet, 2011, 56(8):595-601.
[20].Ferlay J., I. Soerjomataram, M. Ervik, et al. 2013. GLOBOCAN 2012 V1.0, Cancer Incidence and Mortality Worldwide: IARC Cancerbase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer.http://globocan.iarc.fr. 192
[21].Hardisson D. Molecular pathogenesis of head and neck squamous cell　carcinoma.[J]. Eur Arch Otorhinolaryngol,2003,260(9):502-8
[22]. S. Müller, Y. Pan, R. Li, et al. Changing trends in oral squamous cell carcinoma with particular reference to young patients:1971-2006. The Emory University experience.[J]. Head Neck Pathol,2008,2, 60-6
[23].A.R. Fakih, R.S. Rao, A.M. Borges, et al. Elective versus therapeutic neck dissection in early carcinoma of the oral tongue.[J]. Am. J. Surg,1989, 158, 309-313
[24]. K. Rusthoven, A. Ballonoff, D. Raben, et al. Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.[J]. Cancer,2008,112, 345-351
[25]. Choi S, Myers JN.Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy.[J]. J Dent Res, 2008, 87(1):14-32.
[26]. Hashibe M, Brennan P, Chuang SC, et al: Interaction between tobacco and alcohol use and the risk of head and neck cancer: Pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol Biomarkers Prev, 2009, 18:541-550
[27].Kurihara M, Kirita T, Sasahira T ,et al .Protumoral roles of　melanoma inhibitory activity 2 in oral squamous cell carcinoma.[J]. Br J Cancer, 2013, 108(7):1460-9
[28]. National Cancer Institute: Surveillance, Epidemiology, and End Results (SEER) Program, National Cancer Institute Surveillance Research Program, series 9 (1996-2003), 2006
[29].Harris L, Sessions R, Hong W. Head and neck cancer: a multidisciplinary approach. Philadelphia: Lippincott-Raven; 1998.
[30]. Edge SB BD, Compton CC, Fritz AG, et al:AJCC cancer staging manual (ed 7). New York, NY, Springer, 2010
[31]. Williams HK. Molecular pathogenesis of oral squamous carcinoma.[J].Mol Pathol, 2000, 53(4):165-172.
[32].J. Ferlay, I. Soerjomataram, R. Dikshit.et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.[J].International Journal of Cancer, 2015, 136( 5): 359-86.
[33].Hill BT, Price LA. Lack of survival advantage in patients with advanced squamous cell carcinomas of the oral cavity receiving neoadjuvant chemotherapy prior to local therapy, despite achieving an initial high clinical complete remission rate.[J]. Am J Clin Oncol, 1994, 17 (1):1-5.
[34].Brocklehurst PR, Baker SR, Speight PM. Oral cancer screening:what have we learnt and what is there still to achieve.[J].Future Oncol, 2010, 6(2):299-304.
[35].Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: Globocan 2008[J]. Int J Cancer, 2010, 127(12): 2893-917.
[36].Shah JP, Gil Z. Current concepts in management of oral cancer surgery.[J]. Oral Oncol, 2009, 45(4-5):394-401.
[37].Chen W, Zheng R, Zuo T, et al．National cancer incidence and mortality in China, 2012.[J].Chin J Cancer Res, 2016, 28(1):1-11.
[38].de Vicente JC, Rodriguez-Santamarta T, Rosado P, et al. Survival after free flap reconstruction in patients with advanced oral squamous cell carcinoma.[J]. J Oral Maxillofac Surg, 2012, 70(2):453-9.
[39].Patel SG, Amit M, Yen TC, et al. Lymph node density in oral cavity cancer: results of the International Consortium for Outcomes Research[J]. Br J Cancer, 2013, 109(8):2087-95.
[40].Patel SC, Carpenter WR, Tyree S, et al: Increasing incidence of oral tongue squamous cell　carcinoma in young white women, age 18 to 44 years.[J]. J Clin Oncol, 2011, 29:1488-94.
[41].Chinn SB, Spector ME, Bellile EL, et al: Impact of perineural invasion in the pathologically N0　neck in oral cavity squamous cell carcinoma.[J].Otolaryngol Head Neck Surg, 2013,149: 893-899
[42].Myers JN, Greenberg JS, Mo V, et al: Extracapsular spread: A significant predictor of treatment　failure in patients with squamous cell carcinoma of　the tongue.[J].Cancer, 92: 3030-3036, 2001
[43]. Greenberg JS, Fowler R, Gomez J, et al: Extent of　extracapsular spread: A critical prognosticator in oral　tongue cancer.[J].Cancer, 97:1464-1470, 2003

Current situation of oral squamous cell carcinoma

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	. A study of the relationship between XIAP expression and oral squamous cell carcinoma lymph node metastasis [J]. , 2018, 38(2): 146-148.
[2]	. Preparation of folate-chitosan loaded decitabine nanoparticles and targeting inhibition effect on tongue carcinoma cells [J]. , 2017, 37(11): 997-1001.
[3]	. Effect of staurosporine on cell proliferation and apoptosis in oral squamous cell carcinoma cell line CAL27 [J]. , 2017, 37(7): 598-602.
[4]	Yu XueDi. Application of metabolomics in study on biomarkers for oral carcinoma and oral precancerous lesions [J]. , 2017, 37(4): 369-372.
[5]	. The expressions of Slug and E-cadherin in oral squamous cell carcinoma [J]. , 2017, 37(3): 214-218.
[6]	. Expression and clinical significance of SATB2,NANOG and OCT4 in oral squamous cell carcinomas [J]. , 2015, 35(12): 1016-1019.
[7]	. Study on the expression of TLR3 and TLR4 with the stimulation of hypoxia in OSCC cell lines [J]. , 2015, 35(10): 806-809.
[8]	. Roles of EMT in the pathologic mechanism of oral squamous cell carcinoma and lichen planus [J]. , 2015, 35(4): 296-301.
[9]	. Clinical and pathological characteristics of acinic cell carcinoma of alveolar process: A case report and review of literature [J]. , 2014, 34(12): 953-955.
[10]	. Preliminary evaluation of pre-operation induction chemotherapy with TPF for advanced oral squamous cell carcinoma [J]. , 2014, 34(10): 734-736.
[11]	. Expression of Livin in oral squamous cell carcinoma [J]. , 2014, 34(8): 573-575.
[12]	. Expression and clinical significance of Cyasatin B and Cystatin C in tongue squamous cell carcinoma [J]. , 2014, 34(8): 576-579.
[13]	. Efect of neoadjuvant chemotherapy on Survivin expression in Oral squamous cell carcinoma [J]. , 2013, 33(10): 683-685.
[14]	. Expression of CD44v5 and CD44v7 in oral squamous cell carcinomas and its clinical significance [J]. , 2013, 33(4): 221-224.
[15]	. Expression of chemokine receptor CXCR4 and CCR7 in oral squamous cell carcinoma and their relation to clinicopathological characteristics [J]. , 2013, 33(1): 8-12.